LongevityNext

Intervention

Azelaprag

Source-reviewedGoverned LongevityNext intelligence profile
Evidence reviewed through2026-08-07

Executive intelligence snapshot

Current reviewed view

Dosing was discontinued after liver transaminitis observations, and the sponsor later terminated azelaprag development while retaining interest in structurally distinct APJ agonists.

This profile includes 2 reviewed relationship(s) and 5 reviewed source(s).

This view is bounded by reviewed evidence and does not provide a recommendation or a claim beyond the stated review date.

Evidence state

Source-reviewed

Evidence reviewed through2026-08-07

Evidence state

What the evidence supports

Dosing was discontinued after liver transaminitis observations, and the sponsor later terminated azelaprag development while retaining interest in structurally distinct APJ agonists.

Evidence boundary

Key limitations

  • The public evidence does not establish that APJ agonism is intrinsically hepatotoxic or that the broader target class lacks therapeutic potential.

    Does not establish efficacy, mechanism falsification, approval, utility, rejuvenation, or investment attractiveness.

Not established

Key unknowns

  • Dose, route, population, and outcomes not recorded in this reviewed profile remain unknown.

    The reviewed evidence does not resolve this dimension beyond the recorded boundary.

Next evidence milestone

What would change this view?

No specific evidence milestone is recorded yet.

Evidence reviewed through 2026-08-07.

Intelligence connections

Reviewed source layer

Evidence & sources

These cards show only metadata present in the reviewed source registry.

Reviewed source

Reviewed source metadata is limited.

Reviewed source

Reviewed source metadata is limited.

Reviewed source

Reviewed source metadata is limited.

Technical provenance
Object key
intervention:LNPG-ENT-c4342109-264e-4c61-9e6d-aa4e453350a7
Source release
LNPG-REL-20260807-027
Mapping version
0.2.0
Presentation release
LNPG-REL-20260808-037
Projection hash
79ae37979515adf9e6dca4c587ad1fdc1d9abff4ea88afa1dc851d0940cfbea7

Source identifiers

  • LNPG-SRC-01c0285b-3801-4c68-9fbc-acea999fed83
  • LNPG-SRC-380a1ac4-6023-4ee4-aace-600fcbad50c4
  • LNPG-SRC-52cf3f8a-cb4d-4456-af50-baad731be1cd
  • LNPG-SRC-b61e9777-5497-4482-aaf1-f98b0b209e9e
  • LNPG-SRC-d32e7414-edf5-455c-9b67-de6e83a35ad7

Directed relationship identities

  • edge:00204 — intervention_exactly_links_company
  • edge:00212 — intervention_tested_in_trial

Scores are not displayed because no score methodology is qualified for this profile.

Presentation contract

Snapshot mode
DIRECT_GOVERNED_SUMMARY
Opens in a new tab